A randomized phase III trial evaluating the role of axillary lymph node dissection in breast cancer patients (ct1-3 n1) who have positive sentinel lymph node disease after neoadjuvant chemotherapy.

IRB 14-211
Cancer - Breast, Cancer
Seth Kaufman, MD

D’Amour Center for Cancer Care

3350 Main Street
Springfield, MA 01199

The purpose of this study is to evaluate the role of axillary lymph node dissection in breast cancer patients.
Breast Cancer patients with positive sentinel lymph node disease after neoadjuvant chemotherapy
Rae Lynn Defeo
413-794-0255